304 related articles for article (PubMed ID: 29880555)
41. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA
Lee JM; Kim JB; Uhm JS; Pak HN; Lee MH; Joung B
Heart Rhythm; 2017 Sep; 14(9):1297-1301. PubMed ID: 28559088
[TBL] [Abstract][Full Text] [Related]
42. CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the Bleeding with Antithrombotic Therapy Study.
Toyoda K; Yasaka M; Uchiyama S; Iwade K; Koretsune Y; Nagata K; Sakamoto T; Nagao T; Yamamoto M; Gotoh J; Takahashi JC; Minematsu K;
Hypertens Res; 2014 May; 37(5):463-6. PubMed ID: 24196199
[TBL] [Abstract][Full Text] [Related]
43. [Diagnostic value of copeptin and cancer antigen 125 in acute heart failure patients with atrial fibrillation and their correlations with short-term cardiovascular events].
Ding Y; Wang Q; Yang Y; Wang L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Nov; 30(11):1024-1028. PubMed ID: 30541639
[TBL] [Abstract][Full Text] [Related]
44. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
45. D-dimer is not a long-term prognostic marker following acute cerebral ischemia.
Squizzato A; Ageno W; Finazzi S; Mera V; Romualdi E; Bossi A; Venco A
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):303-6. PubMed ID: 16651873
[TBL] [Abstract][Full Text] [Related]
46. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
[TBL] [Abstract][Full Text] [Related]
47. CHA
Guerra F; Scappini L; Maolo A; Campo G; Pavasini R; Shkoza M; Capucci A
Eur Heart J Acute Cardiovasc Care; 2018 Apr; 7(3):264-274. PubMed ID: 27708110
[TBL] [Abstract][Full Text] [Related]
48. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
[TBL] [Abstract][Full Text] [Related]
49. Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.
Joundi RA; Cipriano LE; Sposato LA; Saposnik G;
Stroke; 2016 May; 47(5):1364-7. PubMed ID: 27026630
[TBL] [Abstract][Full Text] [Related]
50. Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients.
Nezu T; Kitano T; Kubo S; Uemura J; Yamashita S; Iwanaga T; Inoue T; Hosomi N; Maruyama H; Matsumoto M; Kimura K; Yagita Y
J Neurol; 2018 Mar; 265(3):628-636. PubMed ID: 29372390
[TBL] [Abstract][Full Text] [Related]
51. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
52. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.
Abualnaja S; Podder M; Hernandez AF; McMurray JJ; Starling RC; O'Connor CM; Califf RM; Armstrong PW; Ezekowitz JA
J Am Heart Assoc; 2015 Aug; 4(8):e002092. PubMed ID: 26304935
[TBL] [Abstract][Full Text] [Related]
53. Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation.
Skov J; Sidelmann JJ; Bladbjerg EM; Jespersen J; Gram J
Thromb Res; 2014 Sep; 134(3):717-22. PubMed ID: 25042725
[TBL] [Abstract][Full Text] [Related]
54. Brain natriuretic peptide in acute ischemic stroke.
Maruyama K; Shiga T; Iijima M; Moriya S; Mizuno S; Toi S; Arai K; Ashihara K; Abe K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(5):967-72. PubMed ID: 24119617
[TBL] [Abstract][Full Text] [Related]
55. Echocardiographic parameters versus CHA2DS2-VASc score in prediction of overall cardiac events, heart failure, and stroke in non-valvular atrial fibrillation.
Yang LT; Tsai WC; Su HM
Cardiol J; 2018; 25(1):60-71. PubMed ID: 28714523
[TBL] [Abstract][Full Text] [Related]
56. Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation.
Liang Z; Dong Z; Guo M; Shen Z; Yin D; Hu S; Hai X
J Biochem Mol Toxicol; 2019 Feb; 33(2):e22246. PubMed ID: 30370581
[TBL] [Abstract][Full Text] [Related]
57. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients.
Yashiro Y; Arimoto T; Hashimoto N; Tamura H; Iwayama T; Ishigaki D; Kumagai Y; Nishiyama S; Takahashi H; Shishido T; Miyamoto T; Watanabe T; Kubota I
Circ J; 2015; 79(1):61-9. PubMed ID: 25391906
[TBL] [Abstract][Full Text] [Related]
58. [Plasma D-dimer volume as a subclinical marker of thrombotic risk in elderly patients with atrial fibrillation.].
Zadvorev SF; Zamytskaya AA; Piskunov DP; Pushkin AS; Yakovlev AA
Adv Gerontol; 2019; 32(3):415-421. PubMed ID: 31512429
[TBL] [Abstract][Full Text] [Related]
59. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
[TBL] [Abstract][Full Text] [Related]
60. Multiscale Entropy of the Heart Rate Variability for the Prediction of an Ischemic Stroke in Patients with Permanent Atrial Fibrillation.
Watanabe E; Kiyono K; Hayano J; Yamamoto Y; Inamasu J; Yamamoto M; Ichikawa T; Sobue Y; Harada M; Ozaki Y
PLoS One; 2015; 10(9):e0137144. PubMed ID: 26325058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
